Learning Objectives:
- The learner will be able to explain CAR-T including its history, what is involved in the therapy, the specific conditions it’s used for as well as examples of ongoing clinical trials.
- The learner will be able to understand how to accelerate CGT trials including faster regulatory approvals, scaling manufacturing, site readiness and incorporating real‑world data,
- The learner will be able to explain how to operationalize CAR‑T clinical trials at sites in Canada and the benefits of standardized networks, capacity planning, digital coordination, and safe infusion administration.
Join us April 23 for this exciting event. Members are FREE (you need to log in to get your free ticket) and others are just $25.
About Celin:
